Mustang Bio, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Subsequent Events (Details)

Subsequent Events (Details)						1 Months Ended	12 Months Ended
Subsequent Events (Details)	May 10, 2025 USD ($)	Feb. 05, 2025 USD ($) $ / shares shares	Jan. 15, 2025 shares	Jan. 06, 2025 shares	Oct. 25, 2024 USD ($) $ / shares shares	Feb. 28, 2025 USD ($)	Dec. 31, 2024 USD ($) $ / shares shares	Oct. 31, 2024 $ / shares shares	Oct. 24, 2024 $ / shares shares	May 31, 2024 shares	Apr. 29, 2024 $ / shares	Dec. 31, 2023 $ / shares	Oct. 26, 2023 shares	Dec. 31, 2022 $ / shares
Subsequent Events
Reverse split ratio							0.02
Common stock par value (in dollars per share) \| $ / shares							$ 0.0001					$ 0.0001
Warrant exercise price (in dollars per share) \| $ / shares							$ 14.56					$ 67.16		$ 1,152.94
Price per share \| $ / shares											$ 11.85
Net proceeds of offering \| $							$ 11,200,000
Prefunded Warrants
Subsequent Events
Warrants issued							62,100			314,352			33,364
Series A-3 warrant
Subsequent Events
Warrants issued									337,552
Warrant exercise price (in dollars per share) \| $ / shares								$ 11.85	$ 11.85
Cash fee as percentage of aggregate gross proceeds					7.00%
Non accountable expenses, reimbursed \| $					$ 25,000
Management fee as percentage of gross proceeds					1.00%
Placement Agents Warrants
Subsequent Events
Warrants issued					20,251		7,355	20,251		20,251			3,104
Warrant exercise price (in dollars per share) \| $ / shares					$ 14.815
Subsequent events
Subsequent Events
Reverse split ratio			0.02	0.02
Fractional shares of reverse stock split			0	0
Net proceeds of offering \| $	$ 6,900,000
Purchase price \| $		$ 1,000,000
Subsequent events \| February 2025 Public Offering
Subsequent Events
Common stock par value (in dollars per share) \| $ / shares		$ 0.0001
Issuance of common shares (in shares)		495,000
Warrant exercise price (in dollars per share) \| $ / shares		$ 0.0001
Price per share \| $ / shares		$ 3.01
Net proceeds of offering \| $		$ 6,900,000				$ 6,900,000
Non accountable expense allowance \| $		25,000
Clearing expenses \| $		$ 15,950
Subsequent events \| February 2025 Public Offering \| Series C-1 Warrants
Subsequent Events
Warrants issued		2,657,807
Number of warrant to converted		1
Number of common stock, each warrant get converted		1
Warrants expiration term		5 years
Subsequent events \| February 2025 Public Offering \| Series C-2 Warrants
Subsequent Events
Warrants issued		2,657,807
Number of common stock, each warrant get converted		1
Warrants expiration term		24 months
Subsequent events \| February 2025 Public Offering \| Prefunded Warrants
Subsequent Events
Warrants issued		2,162,807
Price per share \| $ / shares		$ 3.0099
Subsequent events \| February 2025 Public Offering \| Series A-3 warrant
Subsequent Events
Cash fee as percentage of aggregate gross proceeds		7.00%
Management fee as percentage of gross proceeds		1.00%
Subsequent events \| February 2025 Public Offering \| Placement Agents Warrants
Subsequent Events
Warrants issued		159,468
Warrant exercise price (in dollars per share) \| $ / shares		$ 3.7625
Offering percentage		125.00%
Offering percentage sold		6.00%
Termination of warrant		5 years
Subsequent events \| Minimum
Subsequent Events
Reverse split ratio			0.02
Subsequent events \| Maximum
Subsequent Events
Reverse split ratio			0.1
Subsequent events \| Maximum \| February 2025 Public Offering
Subsequent Events
Fees and expenses \| $		$ 100,000
Road show expenses \| $		$ 3,500